The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials

BACKGROUND: The efficacy of adding panitumumab to chemotherapy remains controversial in the treatment of metastatic colorectal cancer (mCRC). Thus, we conducted this meta-analysis to assess the efficacy and safety of this combination regimen in patients with mCRC. METHODS: The PubMed, Embase, and We...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ruo-feng, Zheng, Lei-lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535553/
https://www.ncbi.nlm.nih.gov/pubmed/26300630
http://dx.doi.org/10.2147/DDDT.S85178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535553/
https://www.ncbi.nlm.nih.gov/pubmed/26300630
http://dx.doi.org/10.2147/DDDT.S85178

Ejemplares similares